Adaptam Therapeutics

Developer of antibody-based immunotherapies targeting the immunosuppressive myeloid tumor microenvironment

placeSan Sebastian, Basque Country, Spain calendar_todayFounded 2023 language adaptamtx.com

Innovation

2 patent families — focus: Chemistry & metallurgy; filing pace active. Cited 256 times.

YearFilings
20252
20261

Social engagement

Social engagement: 644 social following, 1 post in the last 12 months — below the industry typical range.

Investor mix

1 investor on record; lead investors include Criteria Bio Ventures.

Investor typeCountShare
Venture capital1100%
Coming soon